Post-marketing surveillance of long-term administration of Inovelon tablets in patients with Lennox-Gastaut syndrome
Not Applicable
Recruiting
- Conditions
- ennox-Gastaut syndrome
- Registration Number
- JPRN-jRCT1080222123
- Lead Sponsor
- Eisai Co., Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- recruiting
- Sex
- All
- Target Recruitment
- 300
Inclusion Criteria
All patients with Lennox-Gastaut syndrome and administrated Inovelon
Exclusion Criteria
None
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method safety<br>efficacy<br>Frequency of attacks<br>Whole improvement level
- Secondary Outcome Measures
Name Time Method other<br>None